Quality-of-life assessment of fibroid treatment options and outcomes

Radiology

Volumn 259, Issue 3, 2011, Pages 785-792

  Fennessy, Fiona M ^a   Kong, Chung Yin ^b   Tempany, Clare M ^a   Swan, J Shannon ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; COMPUTER ASSISTED SURGERY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; VISUAL ANALOG SCALE;

ADULT; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRASONIC THERAPY; UTERINE ARTERY EMBOLIZATION; UTERINE NEOPLASMS;

EID: 79956308103     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11100704     Document Type: Article

References (40)

1. Stewart EA. Uterine fibroids. Lancet 2001;357(9252):293-298. (Pubitemid 32120866)
2. Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 2006;195(4):955-964. (Pubitemid 44415640)
3. Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 2006;108(4):930-937. (Pubitemid 44498255)
4. Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Uterine artery embolization. Obstet Gynecol 2004;103(2):403-404.
5. Fennessy FM, Tempany CM. MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol 2005;12(9):1158-1166. (Pubitemid 41160563)
6. Fennessy FM, Tempany CM. A review of magnetic resonance imaging-guided focused ultrasound surgery of uterine fibroids. Top Magn Reson Imaging 2006;17(3):173-179. (Pubitemid 46586209)
7. Lénárd ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - imaging predictors of success. Radiology 2008;249(1):187-194.
8. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006;85(1):22-29. (Pubitemid 43063413)
9. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003;226(3):897-905. (Pubitemid 36259169)
10. Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - results of different treatment protocols. Radiology 2007;243(3):885-893. (Pubitemid 46799445)
11. Froberg DG, Kane RL. Methodology for measuring health-state preferences. II. Scaling methods. J Clin Epidemiol 1989;42(5):459-471. (Pubitemid 19165912)
12. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993;13(2):89-102. (Pubitemid 23113445)
13. Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357(9252):273-277. (Pubitemid 32120860)
14. Swan JS, Fryback DG, Lawrence WF, Sainfort F, Hagenauer ME, Heisey DM. A time-tradeoff method for cost-effectiveness models applied to radiology. Med Decis Making 2000;20(1):79-88. (Pubitemid 30036266)
15. Swan JS, Lawrence WF, Roy J. Process utility in breast biopsy. Med Decis Making 2006;26(4):347-359. (Pubitemid 44050840)
16. Hrung JM, Langlotz CP, Orel SG, Fox KR, Schnall MD, Schwartz JS. Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions. Radiology 1999;213(1):39-49. (Pubitemid 29470403)
17. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 2006;98(11):774-782. (Pubitemid 43983301)
18. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16(3):199-208.
19. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7(2):118-133.
20. Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Socioecon Plann Sci 1976;10(3):129-136.
21. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7(10):1342-1346. (Pubitemid 23042150)
22. Swan JS, Sainfort F, Lawrence WF, Kuruchittham V, Kongnakorn T, Heisey DM. Process utility for imaging in cerebrovascular disease. Acad Radiol 2003;10(3):266-274. (Pubitemid 36259200)
23. Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, De Haes HJ. The 'utility' of the visual analog scale in medical decision making and technology assessment: is it an alternative to the time trade-off? Int J Technol Assess Health Care 1996;12(2):291-298.
24. Loomes G. Disparities between health state measures: an explanation and some implications. York, England: University of York, 1988.
25. Conover W. Practical nonparametric statistics. New York, NY: Wiley, 1999.
26. Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 2004;230(1):207-213. (Pubitemid 37549803)
27. Zowall H, Cairns JA, Brewer C, Lamping DL, Gedroyc WM, Regan L. Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG 2008;115(5):653-662. (Pubitemid 351357573)
28. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21(2):271-292. (Pubitemid 34143147)
29. Beresniak A, Russell AS, Haraoui B, Bessette L, Bombardier C, Duru G. Advantages and limitations of utility assessment methods in rheumatoid arthritis. J Rheumatol 2007;34(11):2193-2200. (Pubitemid 350076878)
30. Duru G, Auray JP, Béresniak A, Lamure M, Paine A, Nicoloyannis N. Limitations of the methods used for calculating quality-adjusted life-year values. Pharmacoeconomics 2002;20(7):463-473. (Pubitemid 34804175)
31. Stiggelbout AM. Health state classification systems: how comparable are our cost-effectiveness ratios? Med Decis Making 2006;26(3):223-225.
32. Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care 2003;41(7):791-801.
33. Marra CA, Woolcott JC, Kopec JA, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60(7):1571-1582. (Pubitemid 40126441)
34. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine: Oxford, England: Oxford University Press, 1996.
35. Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999;3(9):i-iv, 1-164.
36. O'Leary JF, Fairclough DL, Jankowski MK, Weeks JC. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship. Med Decis Making 1995;15(2):132-137.
37. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99(2):290-300. (Pubitemid 34114003)
38. Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol 2008;111(1):22-33.
39. Swan JS, Miksad RA. Measuring the quality-of-life effects of diagnostic and screening tests. J Am Coll Radiol 2009;6(8):567-575.
40. Yin D, Baum RA, Carpenter JP, Langlotz CP, Pentecost MJ. Cost-effectiveness of MR angiog raphy in cases of limb-threatening peripheral vascular disease. Radiology 1995;194(3):757-764.